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Abstract: ETHE1 (ethylmalonic encephalopathy protein 1) is a β-lactamase
fold-containing protein that is essential for the survival of a range of
organisms. In spite of the apparent importance of this enzyme, very little is
known about its function or biochemical properties. In this study Arabidopsis
ETHE1 was over-expressed and purified and shown to bind tightly to 1.2 ±

Journal of Inorganic Biochemistry, Vol. 102, No. 9 (September 2008): pg. 1825-1830. DOI. This article is © Elsevier and
permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

1

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

0.2 equivalents of iron. 1H NMR and EPR studies demonstrate that the
predominant oxidation state of Fe in ETHE1 is Fe(II), and NMR studies confirm
that two histidines are bound to Fe(II). EPR studies show that there is no
antiferromagnetically-coupled Fe(III)Fe(II) center in ETHE1. Gel filtration
studies reveal that ETHE1 is a dimer in solution, which is consistent with
previous crystallographic studies. Although very similar in terms of amino acid
sequence to glyoxalase II, ETHE1 exhibits no thioester hydrolase activity, and
activity screening assays reveal that ETHE1 exhibits low level esterase
activity. Taken together, ETHE1 is a novel, mononuclear Fe(II)-containing
member of the β-lactamase fold superfamily.
Keywords: β-lactamase fold, Fe(II), ETHE1, NMR spectroscopy, EPR
spectroscopy

Introduction
Mutations in the ethylmalonic encephalopathy protein 1 (ETHE1)
are responsible for the complex human disease ethylmalonic
encephalopathy (EE) [1, 2]. The symptoms of EE are well
characterized, yet the underlying physiological cause of the disease
remains unknown [1]. Symptoms associated with EE include chronic
diarrhea, a delay in neural development, symmetric brain lesions,
relapsing petechiae, lactic academia, and acrocyanosis of the hands
and feet, all of which lead to death within the first few years of life [3].
Biochemical alterations associated with of EE include elevated levels of
C4 and C5 plasma acylcarnitines and elevated levels of ethylmalonic
acid (EMA). Based on these biochemical alterations, it has been
suggested that ETHE1 may be involved in the β-oxidation of shortchain acyl-CoAs [1].
ETHE1-like enzymes are found in most organisms including
archaebacteria, insects, plants, and animals, suggesting that ETHE1
serves a fundamental biochemical role in nature; however, the exact
biochemical role of ETHE1 is currently unknown. ETHE1 is most similar
to the glyoxalase II family of proteins that catalyze the second step of
the glyoxalase pathway. The glyoxalase pathway, which consists of
glyoxalase I (lactoylglutathione lyase) (GLX1) and glyoxalase II
(hydroxacylglutathione hydrolase) (GLX2), is thought to be involved in
the detoxification of 2-oxoaldehydes, toxic by-products of
carbohydrate and lipid metabolism [4]. The primary physiological
substrate appears to be methylglyoxal (2-oxopropanal), a reactive αoxoaldehyde [4].
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GLX2 enzymes belong to the metallo-β-lactamase fold family of
proteins, which are typically dinuclear metallohydrolases. The metalloβ-lactamases typically bind two equivalents of Zn(II) and hydrolyze βlactams [5, 6]. GLX2 enzymes, which hydrolyze SLG, contain dinuclear
metal centers that can bind Zn, Fe, and Mn [7]. Additional protein
families containing the β-lactamase fold include the rubredoxin:oxygen
oxidoreductase (ROO) and ZiPD families, which have been shown to
bind divalent Fe and Zn(II), respectively [8, 9]. Therefore, the βlactamase fold can accommodate several different metals and is
present in enzymes that can catalyze a wide range of reactions.
Arabidopsis ETHE1 is 54% identical to human ETHE1. Crystal
structure comparisons between Arabidopsis ETHE1 [10] and
Arabidopsis GLX2-5, a mitochondrial GLX2 enzyme [11], revealed that
while the proteins show only 13% sequence identity, ETHE1 is
structurally very similar to GLX2 [12]. ETHE1 and GLX2 enzymes
contain a very similar metal binding domain and the β-lactamase fold
consisting of two central mixed β-sheets surrounded on both sides by
helices [12, 13]. Interestingly, even though ETHE1 and GLX2 enzymes
exhibit extensive similarity in their metal binding regions, the ETHE1
crystal structure showed it only bound a single metal atom [12]. In
fact, the crystal structure was best refined to a metal occupancy of 0.5
[12]. However, the metal content of purified ETHE1 was reported to be
2 equivalents of metal per equivalent of protein, raising the question of
the actual metal content of this enzyme.
We have over-expressed, purified, and biochemically- and
spectroscopically-characterized Arabidopsis ETHE1 to further
investigate structural and biochemical properties of ETHE1 enzymes
and to better understand the functional role of ETHE1. The results of
these studies show that Arabidopsis ETHE1 is homodimeric in solution,
exhibits low-level esterase activity, and specifically binds a single
Fe(II) atom in the active site.
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Materials and Methods
Over-expression and purification of A.t. ETHE1
The Arabidopsis ETHE1 cDNA was obtained from Arabidopsis
bud RNA and cloned into pET24b as Nde1 and XhoI fragments
following reverse transcription and PCR amplification using the primers
GLX2-3 (TCTTCTCATATGAAGCTTCTCTTTCGTCAAC) and a 3′poly (A)
anchor primer. During cloning the N-terminal leader peptide was
removed for high-level expression of ETHE1 in E. coli, resulting in the
amino terminal methionine, which corresponds to amino acid 50 of the
predicted protein sequence. This is the same form of the protein that
was used for crystal structure determination [12]. After verification by
DNA sequencing, pET24b-ETHE1 was transformed into BL21-Codon
Plus (DE3)-RIL cells and used for protein over-expression and
purification as previously described [7]. Protein purity was determined
by SDS-polyacrylamide gel electrophoresis, and protein concentrations
were determined by using an extinction coefficient (ε280nm) of 7,240
M−1cm−1, which was determined using amino acid analyses.

Metal analyses
Metal analyses were performed on the purified enzyme using a
Varian-Liberty 150 inductively coupled plasma spectrometer with
atomic emission spectroscopy detection (ICP-AES) as described
previously [13]. The purified protein was diluted to 10 μM in 50 mM
TRIS, pH 7.2, and analyzed for the presence of zinc, manganese, iron,
and copper. The data presented in this report represent the average of
at least three preparations for each metal addition experiment.

Native molecular weight determination
The native molecular weight of ETHE1 was determined by
utilizing a Sephacryl S200 column in 10 mM MOPS, pH 7.2, containing
0.15 M NaCl. ETHE1 (1 mg), purified as described above, was mixed
with 1 mg of each of the protein standards: Blue Dextran, bovine
serum albumin, ovalbumin, aldolase, and ribonuclease A. One milliliter
fractions were collected with a flow rate of 0.5 ml/min, and samples
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containing protein were identified by monitoring A280 and by SDS-PAGE
gel analysis.

Substrate analysis
Enzymatic assays were conducted at 25 ºC in 10 mM MOPS, pH
7.2, on a Cary IE UV-Vis spectrophotometer. A series of thioesters of
glutathione were synthesized as previously described [14], and all
other substrates were purchased commercially. The hydrolysis of S-Dlactoylglutathione (Sigma), S-D-acetylglutathione, S-Dacetoacetylglutathione, S-D-formylglutathione, S-Dglyocosylgutathione or S-D-pyruvylglutathione was monitored at 240
nm. S-D-mandeloylglutathione hydrolysis was monitored at 263 nm
[14]. Hydrolysis of p-nitrophenyl phosphate (Sigma), p-nitrophenyl
sulfate (Sigma), and p-nitrophenyl acetate (Sigma) was monitored at
400 nm [15–17]. The hydrolysis of L-alanine-p-nitroanilide (Sigma)
was measured at 404 nm [16]. Ala-ala-ala-p-nitroanilide (Sigma) and
y-L-Glu-p-nitroanalide (Sigma) hydrolysis was monitored at 410 nm.
Hydrolysis of benzoylglycyl-L-phenylalanine was monitored at 254 nm
[18]. Nitrocefin (Becton-Dickinson) hydrolysis was monitored at 485
nm [19]. Methylglyoxal was assayed colorimetrically by using the 2,3dinitrophenylhydrazine-alkali reaction [20]. Assays were performed for
5 min using 80 μM substrate and varying concentrations of pure
enzyme both as-isolated and after loading with excess iron.
Additional substrate screening was performed using the
Micronaut-Taxa Profile E (Merlin GmbH) microtiter plate [8]. Each well
was filled with 25 μl of 40 μM ETHE1, and reactions prepared according
to manufacturer’s directions. A negative control was performed using
MOPS, pH 7.2, to rule out non-specific reactions. The reactions were
monitored visually for 24 hours at 37 ºC, and positive reactions were
recorded. Each reaction was performed in duplicate using enzyme
loaded with iron.

EPR Spectroscopy
EPR spectra were obtained at 9.63 GHz and 10 K using a Bruker
EleXsys E580 spectrometer equipped with an ER4116DM cavity, and
an Oxford ESR900 liquid helium flow cryostat and ITC503 temperature
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controller. Acquisition parameters included 12 G (1.2 mT) field
modulation at 100 kHz. Samples contained 1.6 mM ETHE1 protein in
50 mM TRIS, pH 7.2.
1

H NMR Spectroscopy

NMR spectra were collected on a Bruker Avance 500
spectrometer operating at 500.13 MHz, 298 K, and a magnetic field of
11.7 tesla, recycle delay (AQ), 41 ms, and sweep width, 400 ppm.
Concentrated samples of ETHE1 (1.4 mM) contained 10% D2O for
locking or 90% D2O for monitoring of solvent-exchangeable peaks.
Protein chemical shifts were calibrated by assigning the H2O signal a
value of 4.70 ppm, and a modified presaturation pulse sequence
(zgpr) was used to suppress the proton signals that originated from
the water molecules.

Results
Over-expression, purification, and characterization of
Arabidopsis ETHE1
Based on publicly-available localization prediction programs (pSORT II,
Mitoprot), recombinant ETHE1 was cloned into the pET24b expression
vector after removing the predicted 50 amino acid N-terminal leader
sequence, which generated an N-terminus of MKLLFRQ (Figure 1). This
plasmid was transformed into E. coli BL21(RIL) Rosetta cells, and
ETHE1 was over-expressed as described in Material and Methods.
ETHE1 was purified using FPLC Q-Sepharose chromatography, eluting
from the column at ~125 mM NaCl. Purified ETHE1 protein was
obtained in high yield (~40–60 mg of protein/L) and was >95% pure
(data not shown).

Journal of Inorganic Biochemistry, Vol. 102, No. 9 (September 2008): pg. 1825-1830. DOI. This article is © Elsevier and
permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

6

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 1: Sequence Alignment of ETHE1 and select metallo-β-lactamase fold
proteins
Protein sequences were aligned using CLUSTAL W (1.83). Identical residues are
highlighted with black and similar residues with gray highlight. Conserved metal
binding ligands are indicated by closed triangles. Residues labeled with an asterisk are
mutated in patients with EE. Predicted N-terminal processing site is indicated by an
arrow.

ETHE1 is a dimer in solution
In contrast to the GLX2 enzymes, which exist as monomers in
solution [21, 22], the crystal structure of Arabidopsis ETHE1 suggested
that it has a dimeric quaternary structure [12]. Gel filtration studies
were performed on the recombinant ETHE1 enzyme to test this
hypothesis. ETHE1 eluted from a Sephacryl S200 column between
standard proteins adolase (158 kDa) and ovalbumin (44 kDa),
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resulting in a calculated molecular weight of 58.3 kDa, which is
roughly twice the recombinant monomeric weight of 26.8 kDa (Figure
2). Therefore, Arabidopsis ETHE1 exists as a dimer in solution.

Figure 2: Gel filtration elution profile of internal protein standards and ETHE1
Approximately 1 mg of each of the following internal protein standards was separated
on a Sephacryl S200 column: blue dextran, bovine serum albumin, ovalbumin,
aldolase, and ribonuclease A. Protein containing fractions were monitored by A280 as
well as by SDS-PAGE.

Metal Analyses
GLX2 enzymes have been shown to bind iron, zinc, and
manganese; therefore, ETHE1 was analyzed for all three of these
metals and also copper [11, 23]. The preparation of ETHE1 in rich
medium containing no added metal ions resulted in an isolated enzyme
that bound 0.2 equivalents of iron and no other metal ions at levels
detectable with ICP-AES. When grown and over-expressed in rich
medium containing 250 μM Fe(NH4)2(SO4)2 and Zn(SO4)2 or 250 μM
MnCl2, ETHE1 was found to contain 0.33 ± 0.10 equivalents of iron
and less than 0.003 equivalents of zinc, manganese, and copper. While
low, this result suggested that ETHE1 may preferentially bind iron. The
purified enzyme was incubated with a 4-molar excess of Fe(II) and
dialyzed extensively (4X1L for four hours each) to remove loosely- or
unbound Fe, and ETHE1 was found to bind 1.2 ± 0.2 equivalents of
iron, and no detectable traces of zinc, manganese, or copper. This
result is consistent with the crystal structure [12], which showed that
when prepared this way, ETHE1 only binds 1 equivalent of iron. Unlike
the GLX2 enzymes, the addition of excess zinc or manganese to the
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isolated enzyme resulted in no additional metal binding, suggesting
that ETHE1 may be specific for iron.

ETHE1 Does Not Hydrolyze SLG
ETHE1 had previously been predicted to be a GLX2-like enzyme [10].
However, ETHE1 is lacking several highly-conserved amino acids
known to participate in the hydrogen bonding of SLG in GLX2 [12, 13].
Furthermore, crystallographic analysis showed that the substrate
binding pocket of ETHE1 is too small to accommodate SLG [12]. These
results suggested that Arabidopsis ETHE1 does not utilize SLG as a
substrate. ETHE1, both as-isolated and after incubation with excess
iron, was assayed for thioesterase activity with SLG and various other
thioester derivatives of glutathione to test this hypothesis. Consistent
our prediction, purified ETHE1 did not hydrolyze any of the glutathione
thioesters.
As-isolated ETHE1 and Fe-enriched ETHE1 were also assayed
against 188 different substrates, including 95 substrates for
peptidases, 17 substrates for diverse reactions, and 76 substrates for
glycolytic enzymes, phosphatases, and esterases using a
commercially-available substrate screening plate [8] to investigate
potential substrates. Three potential substrates were identified through
this screening process: Ala-Ala-Ala-p-nitroanilide (NA), Glu-pNA, and
p-nitrophenyl acetate (NPA). Upon further characterization, Ala-AlaAla-pNA and Glu-pNA were found not to be substrates for ETHE1.
However, ETHE1 did exhibit a low level of activity against p-NPA (2.02
± 0.46 nmols/min/mg of enzyme). This low level of activity is similar
to the esterase activity (25.8 nmols/min/mg) observed in recombinant
rat carbonic anhydrase III when reacted with p-nitrophenyl acetate
[24]. The activity of ETHE1 towards p-nitrophenyl acetate was
inhibited by the presence of a metal chelator, 1,10-o-phenanthroline,
indicating that p-nitrophenyl acetate hydrolysis by ETHE1 requires
bound metal. Therefore, based on these results and those of the
crystal structure, we predict that the ETHE1 substrate may be a
relatively small ester.
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Spectroscopic Studies on ETHE1
The metal binding site of iron-bound ETHE1 was investigated
using 1H NMR spectroscopy (Figure 3). The spectrum revealed the
presence of 3 paramagnetically-shifted, down field resonances
between 200 and 20 ppm and no observable up field resonances >
−30 ppm. In this spectrum peaks a and c integrate to 1 proton each,
while peak b integrates to 2–3 protons (Figure 3). Spectra were
obtained at 7 °C and 35 °C, and while all three peaks shifted up field
with increasing temperature, peak b did not split into 2 or more peaks,
suggesting that this peak is due to at least 2 chemically-equivalent
protons. To further investigate the identity of these protons, an NMR
spectrum of ETHE1 in 80–90% D2O was obtained (Figure 3). Peaks a
and c broadened slightly but still integrate to 1 proton each. The
intensity of peak b decreased by 85%. Based on the resonance
positions and line widths, peak b can be assigned to two N-H protons
on histidines bound to Fe(II) or possibly to an antiferromagneticallycoupled Fe(III)Fe(II) center [25, 26]. The ETHE1 crystal structure
shows that both of the histidine ligands are bound through the ε
nitrogen, and therefore, peaks a and c are likely due to the β-CH2
protons on the bound Asp ligand (Figure 3). We cannot rule out the
possibility that these peaks are due to ortho protons on metal bound
histidines, but these peaks are usually too broad to detect [27]. The
NMR data were surprising, since we initially predicted that ETHE1
would have a metal binding site similar to those in the GLX2 family.
NMR spectra from GLX2-5, which can contain a dinuclear iron center,
shows at least eight paramagnetically-shifted resonances in between
110 and −30 ppm that correspond to protons on ligands bound to a
Fe(III)Fe(II) antiferromagnetically-coupled center [11]. The recent
crystal structure of ETHE1 demonstrated that His74 (His56 in GLX2-5)
may not be in a position to coordinate a bound metal ion [12], which is
consistent with NMR spectrum of ETHE1.
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Figure 3: 1H NMR spectra of 1.4 mM iron-bound ETHE1 at pH 7.2 in water and
80–90% D2O
The spectra were obtained on a Bruker Avance 500 spectrometer operating at 500.13
MHz, 298 K, and a magnetic field of 11.7 tesla, recycle delay (AQ), 41 ms; sweep
width, 400 ppm.

EPR spectra on several different forms of ETHE1 were obtained
to further investigate the ETHE1 metal center. The spectrum of asisolated ETHE1 containing 0.33 equivalents of Fe (‘Feiso-ETHE1’)
indicated the presence of rhombic Fe(III) (Figure 4). The signal was
dominated by a broad derivative feature at geff = 4.27; no features
that could be considered diagnostic for protein-bound Fe(III) were
observed and the origin of the signal is, therefore, unclear. Although
precise quantitation of high-spin systems for which more than one
Kramers’ doublet is populated is not trivial, double integration and
comparison with a similar EPR signal due to Fe(III) from a wellcharacterized (4-hydroxyphenyl) pyruvate dioxygenase [21] indicated
an Fe(III) content of about 0.025 mM. Therefore about 95 % of the
iron in Feiso-ETHE1 is EPR-silent.
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Figure 4: EPR spectram of 1.6 mM ETHE1 under different conditions
A, ETHE1 as-isolated containing 0.33 equivalents of Fe; B, iron-enriched
ETHE1 containing 1.2 equivalents of Fe; C, iron-enriched ETHE1 after 2 cycles
of freeze/thaw; D, iron-enriched ETHE1 after 4 days at 4º C. Spectra were
collected on a Bruker ESP-300E spectrometer containing an ESR-900 helium
flow cryostat operating at 4.7 K with 2 milliwatts of microwave power at 9.48
GHz and 10 G-field modulation at 100 kHz.

An Fe(III) signal with a resonance at g ~ 4.3 and additional
absorption features at lower field were observed from the analysis of
ETHE1 enzyme containing 1 equivalent of Fe (Fe1-ETHE1) (Figure 4B).
In this spectrum, the resonance positions indicated a dominant zerofield splitting term (i.e., D,E ≫ gβBS; the lower field resonances
centered at g ~ 5.5 and g ~ 9 terminate abruptly at g = 6 and g = 10,
respectively); the lack of resolved structure and the broad absorption
from g ~ 4.3 to g ~ 10 indicate a fairly broad distribution of the
rhombic zero-field splitting parameter (i.e., strains in E/D) and thermal
population of at least two Kramers’ doublets [22]. Again, the signal
was not definitive for site-specific binding of Fe(III) by ETHE1,
although the form of the signal, particularly the inflection on the g ~
4.3 crossover due to incomplete rhombicity (i.e., E/D is slightly less
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than 1/3), is highly reminiscent of the spectrum due to Fe(III) bound to
the active site of the metallo-β-lactamase GOB [26]. The intensity of
the signal was somewhat lower than that of the as-isolated ETHE1 and
accounted for < 1 % of the total iron. Interestingly, there was no
evidence for a ‘g ~ 1.7, 1.8, 1.9’ signal due to an Fe(II)-Fe(III) center
[28].
We attempted to disrupt the protein structure of Fe1-ETHE1 by
applying freeze-thaw cycles, but the EPR signal remained relatively
constant (Figure 4C; fewer scans were averaged). Efforts to produce
more Fe(III) in the sample by addition of hydrogen peroxide resulted
in rapid protein precipitation. The intensity of the Fe(III) signal was
found to increase by a factor of 4 upon aerobic incubation for 100 h at
4 °C (Figure 4D). The form of this spectrum is clearly distinct from
that of Feiso-ETHE1, but still accounts for < 5 % of the total Fe.
Because of a weak background signal due to trace Mn(II) and Cu(II),
the possibility of the presence of a signal due to an Fe(II)-Fe(III)
center cannot be ruled out completely, but the population of such a
center, if not zero, must be very low.

Discussion
Results presented in this work represent the first detailed
characterization of an ETHE1 protein from any organism. ETHE1 is
most similar to the GLX2-family of proteins, which are members of the
metallo-β-lactamase superfamily. This superfamily consists of proteins
that catalyze a wide range of reactions but share the common metal
binding motif H-x-[EH]-x-D-[CRSH]-X50-70-[CSD]-X, which is part of
the common β-lactamase fold [29]. This motif typically consists of two
metal ions that are essential for the activity of the majority of the
enzymes [29]. In most β-lactamase fold containing proteins, the
coordination of the first metal (Zn1 site) is tetrahedral and consists of
three histidines and a bridging hydroxide, while the second metal
binding site (Zn2 site) is trigonal pyramidal. The site 2 metal binding
ligands are more variable but always contain a histidine and aspartic
acid (Figure 5A) [29]. Because of the similarity of ETHE1 to the GLX2
family of enzymes, it was predicted that ETHE1 would also bind two
equivalents of metal. Metal analyses of ETHE1 done prior to this paper
were based on a calculated extinction coefficient of 10,240 M−1cm−1
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[12]. Metal analyses using this extinction coefficient indicated that
iron-bound ETHE1 contained two equivalents of iron; however, the
ETHE1 crystal structure reported only a 0.5 iron metal occupancy [12].
It was originally thought that this discrepancy resulted from the loss of
metal during the crystallization processes [12]. However, results
presented here suggest that the extinction coefficient used for these
experiments is inaccurate. When using amino acid analyses, an
extinction coefficient of 7,240 M−1cm−1 was obtained, which leads to a
metal:protein stoichiometry of 1.2 ± 0.2. This number is consistent
with the ETHE1 crystal structure [12].

Figure 5: Metal binding sites of (A) A. thaliana GLX2-5 and (B) A. thaliana ETHE1. In
GLX2-5, Zn(II) is coordinated by His54, His56, His112, Asp131, and a bridging
hydroxide, and Fe(III) is coordinated by Asp58, His59, His169, Asp131, and the
bridging hydroxide. In ETHE1, Fe(II) is coordinated by His72, His128, Asp153, and
three solvent molecules.
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The crystal used to solve the structure of ETHE1 took several
months to grow, and we were concerned that the resulting structure
was due to an analog of the protein that was not biologically-relevant.
However, consistent with the crystal structure of ETHE1, our
spectroscopic results suggest that ETHE1 contains a single Fe(II) that
is coordinated by two histidines (Figure 3) [12]. GLX2 enzymes
enriched in iron typically contain an antiferromagnically-coupled
Fe(II)-Fe(III) center in their dinuclear metal binding site [11, 23, 30],
due to the positive cooperative metal binding of these proteins.
Results from our EPR studies argue against the presence of an Fe(II)Fe(III) site in ETHE1. Two distinct EPR signals were observed for
ETHE1, both due to magnetically-isolated Fe(III) and both accounting
for only a very small proportion (1 – 5 %) of the total iron. Even
extensive exposure to air was unsuccessful in increasing the Fe(III)
signal. The very low intensities of the Fe(III) signals can either be due
to most of the iron being in the Fe(II) state or most of the iron
residing in an anti-ferromagnetically-coupled S′ = 0 dinuclear site. The
lack of signals due to an Fe(III)-Fe(II) center and the crystallographic
identification of a monometallated active site [12] both argue against a
predominant Fe(III)-Fe(III) S′ = 0 species and support Fe(II) as the
predominant oxidation state of the metal in ETHE1.
Even though ETHE1 contains all of the highly-conserved metal
binding ligands of the metallo-β-lactamase family of proteins [19],
ETHE1 does not bind two equivalents of metal. In agreement with this
result, the crystal structure identified changes in the tertiary structure
of the metal binding domain that do not allow for the coordination of a
second metal atom (Figure 5B) [12]. Based on the amino acid
sequence comparison, we anticipated that the Zn1 site in ETHE1 would
be made up of His72, His74, His128, and Asp153, while the Zn2 site
would have Asp76, His77, Asp153, and His194. In ETHE1, Fe binds to
3 of the 4 ligands in the Zn1 site (His72, His128, and Asp153). A
single-turn helix in ETHE1 containing His74 is pulled away from the
active site, displacing His74 4.4 Å away from the metal atom in ETHE1
relative to GLX2-5. This unwinding of the helix also displaces the side
chains of Asp76 and His77, and the comparable amino acids in GLX2-5
(Asp58 and His59) bind metal in the Zn2 site (Figure 5) [12].
Therefore, subtle changes in protein conformation have displaced
several of the metal binding ligands, ultimately limiting the ability of
ETHE1 to bind two metal ions.
Journal of Inorganic Biochemistry, Vol. 102, No. 9 (September 2008): pg. 1825-1830. DOI. This article is © Elsevier and
permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

15

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

There are other examples of metallo-β-lactamases that only
bind one metal. CphA from Aeromonas hydrophila and GOB-1 from
Elizabethkinga meningosptica both only bind a single Zn(II) atom in
the Zn2 site (Asp, Cys, His) [31, 32]. However, in these enzymes, the
Zn1 site is altered either by the replacement of a histidine with an
asparagine in CphA or a histidine with glutamine in GOB-1 [31–33]. To
our knowledge ETHE1 is the first example of a β-lactamase family
protein that contains all of the conserved metal-binding ligands, yet
only binds one metal ion.
In addition, it has been shown that the presence of soft or hard
ligands in the metal binding site can affect the specificity of the metal
binding [29]. All of the metallo-β-lactamases exclusively bind Zn(II)
[29]. The incorporation of an aspartic acid and an additional histidine
in the Zn2 site likely allows for the variable binding of Fe, Zn, and Mn
seen in the GLX2 enzymes (Figure 5A) [7, 11, 13, 30]. Likewise, the
replacement of two soft ligands by an aspartic acid and a glutamate as
observed in ROO allows the formation of a di-iron center [9, 29].
Interestingly, in the ETHE1 crystal structure, the Fe ion is bound in the
Zn1 site that has been modified by the removal of a histidine and the
shifting the GLX2 bridging aspartic acid to specifically coordinate the
iron (Figure 5B) [12]. The Fe(II) ion is further coordinated by three
water molecules resulting in an octahedrally-bound metal [12, 34],
unlike the tetrahedral coordination of metal normally seen in the Zn1
site of metallo-β-lactamases.
Therefore, ETHE1 proteins appear to represent a new class in
the metallo-β-lactamase fold family of proteins. Although structurally
very similar to the GLX2 enzymes, ETHE1 appears to have evolved to
bind a single iron atom in an octahedral configuration. Metal analyses
and spectroscopic data suggest that unlike GLX2 enzymes ETHE1
tightly binds to a single Fe(II) atom in a modified Zn1 site of the
metallo-β-lactamase metal binding motif. Finally we show that ETHE1
is homodimeric in solution and exhibits low levels of esterase activity,
suggesting that ETHE1 might hydrolyze a short-chain ester. The metal
binding site in ETHE1, with 2 His, 1 Asp, and 3 water molecules (Figure
5B), resemble the 2-His-1-carboxylate facial triad, which has been
reported in a number of O2-utilizing reactions [35, 36]. However,
ETHE1 does not share similar tertiary structural or amino acid
sequence motifs with any of the enzymes known to have the 2-His-1Journal of Inorganic Biochemistry, Vol. 102, No. 9 (September 2008): pg. 1825-1830. DOI. This article is © Elsevier and
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carboxylate facial triad. In addition, a 1H NMR spectrum on a sample of
ETHE1 containing α-ketoglutarate showed no change in the resonance
positions of the paramagnetically-shifted protons, suggesting that
ETHE1 is not an α-ketoglutarate-dependent enzyme (data not shown).
Further experiments are required to further classify the ETHE1
substrate and ultimately understand its biochemical role.
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